Adaptive phenotype drives resistance to androgen deprivation therapy in prostate cancer

BACKGROUND: Prostate cancer (PCa), the second most common cancer affecting men worldwide, shows a broad spectrum of biological and clinical behaviour representing the epiphenomenon of an extreme heterogeneity. Androgen deprivation therapy is the mainstay of treatment for advanced forms but after few...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferrari, Nicoletta, Granata, Ilaria, Capaia, Matteo, Piccirillo, Marina, Guarracino, Mario Rosario, Venè, Roberta, Brizzolara, Antonella, Petretto, Andrea, Inglese, Elvira, Morini, Martina, Astigiano, Simonetta, Amaro, Adriana Agnese, Boccardo, Francesco, Balbi, Cecilia, Barboro, Paola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5721601/
https://www.ncbi.nlm.nih.gov/pubmed/29216878
http://dx.doi.org/10.1186/s12964-017-0206-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5721601/
https://www.ncbi.nlm.nih.gov/pubmed/29216878
http://dx.doi.org/10.1186/s12964-017-0206-x

Ejemplares similares